Severe mpox virus case confirmed in New York City, according to the Health Department.

The New York City Department of Health has reported the first confirmed case of a severe strain of the mpox virus, previously referred to as monkeypox. This announcement marks a significant moment in the ongoing battle against this viral infection. As of Friday, health officials clarified that the case is travel-related, with no evidence of local transmission associated with the clade I strain of the virus.

The NYC Emergency Management Agency emphasized that mpox primarily spreads through close or intimate contact. They provided guidance on who might benefit from vaccination, urging individuals who identify as male, trans, nonbinary, genderqueer, or gender nonconforming, as well as travelers heading to regions where clade I mpox is currently spreading, to consider vaccination. This advisory encourages proactive measures for anyone who perceives themselves to be at risk through sexual or intimate contact.

Clade I of the mpox virus is particularly concerning due to its potential to cause severe symptoms and even fatalities. The observed symptoms include extensive rashes that can occur on both the face and body. According to the National Institutes of Health, the fatality rate for infections from this strain can range significantly, from approximately 1.4% to more than 10%.

In light of these developments, health officials are actively recommending the two-dose JYNNEOS vaccine. This vaccine is instrumental in reducing the likelihood of infection and can mitigate the severity of symptoms for those who do contract the virus.

The mpox virus first surfaced in New York City four years ago, during which thousands were exposed. The strain predominantly affecting individuals in 2022 was clade II, known for being less severe, generating fewer fatalities, and characterized by symptoms such as localized rashes or sores on genital areas and the mouth.

Typically, symptoms of mpox manifest between three to seventeen days following exposure, persisting for approximately two to four weeks. Since the beginning of 2026, around 45 individuals in New York City have tested positive for the mpox virus, with a notable 16 cases reported within just the last month.

In response to the emerging health threat, officials have made vaccination sites readily accessible, providing information through the city’s health department website and encouraging residents to reach out via the 311 hotline for assistance. The proactive approach aims to mitigate further spread and protect the community from this evolving health concern.